CRDL
Cardiol Therapeutics Inc Class A
NASDAQ: CRDL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.38
+5.34% today
Updated 2026-04-30
Market cap
$156.35M
P/E ratio
—
P/S ratio
1,014.87x
EPS (TTM)
$-0.29
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
Cardiol Therapeutics Inc Class A (CRDL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.29M | $-10.89M | $-11.38M | $-9.13M | $-23.55M | $-27.22M | $-25.18M | $-25.06M | $-23.85M |
| Capital expenditures | $29171.00 | $13791.00 | $424305.00 | $40602.00 | $12916.00 | $74709.00 | $64312.00 | $21290.00 | $24484.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $237.00 | $1.65M | $3.27M | $2.77M | $8.50M | $5.01M | $4.16M | $14.28M | $10.70M |
| Free cash flow | $-1.32M | $-10.91M | $-11.80M | $-9.17M | $-23.56M | $-27.30M | $-25.24M | $-25.08M | $-23.88M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — |